by Rakovina Therapeutics | Mar 12, 2026 | Uncategorized
DOWNLOAD VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce that the TSXV...
by Rakovina Therapeutics | Mar 10, 2026 | Uncategorized
DOWNLOAD VANCOUVER, British Columbia, March 5, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce closing of its...
by Rakovina Therapeutics | Feb 23, 2026 | Uncategorized
DOWNLOAD Proposed $1.0 Million Convertible Debenture and Warrant Financing andConcurrent Common Share Private Placement Up to $1.0 MillionIntended to Support Near-Term Operations Vancouver, British Columbia – February 20, 2026 – Rakovina Therapeutics Inc. (TSX-V:...
by Rakovina Therapeutics | Feb 4, 2026 | Uncategorized
DOWNLOAD Highlights: Strategic Validation: Industry feedback confirms Rakovina’s approach targeting PTEN-deficient tumours with brain-penetrant ATR/mTOR inhibitors addresses critical gaps left by recent late-stage clinical setbacks in the field. Expanded Opportunity:...
by Rakovina Therapeutics | Jan 28, 2026 | Uncategorized
Proposed $1.0 million Convertible Debenture and concurrent $600,000 Private Placement Intended to Support Near-Term Operations Board and Management Enhancements Strengthen Governance and Capital Markets ExecutionCurrent Convertible Debenture Maturity Extended; Further...